CLINICAL-EXPERIENCE WITH CIPROFLOXACIN IN THE USA

被引：65

作者：

ARCIERI, G

AUGUST, R

BECKER, N

DOYLE, C

GRIFFITH, E

GRUENWALDT, G

HEYD, A

OBRIEN, B

机构：

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1986年 / 5卷 / 02期

关键词：

D O I：

10.1007/BF02013994

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：220 / 225

页数：6

共 7 条

[1] MULTIPLE-DOSE CIPROFLOXACIN KINETICS IN NORMAL SUBJECTS [J].

ARONOFF, GE ;

KENNER, CH ;

SLOAN, RS ;

POTTRATZ, ST .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (03) :384-388

[2] INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].

BAUERNFEIND, A ;

PETERMULLER, C .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115

[3] CIPROFLOXACIN THERAPY OF INFECTIONS CAUSED BY PSEUDOMONAS-AERUGINOSA AND OTHER RESISTANT-BACTERIA [J].

ERON, LJ ;

HARVEY, L ;

HIXON, DL ;

PORETZ, DM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) :308-310

[4] INVITRO ACTIVITY OF CIPROFLOXACIN (BAY O 9867) [J].

FASS, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :568-574

[5] USE OF CIPROFLOXACIN IN THE TREATMENT OF PSEUDOMONAS-AERUGINOSA INFECTIONS [J].

FOLLATH, F ;

BINDSCHEDLER, M ;

WENK, M ;

FREI, R ;

STALDER, H ;

REBER, H .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1986, 5 (02) :236-240

[6] OPEN, PROSPECTIVE-STUDY OF THE CLINICAL EFFICACY OF CIPROFLOXACIN [J].

RAMIREZ, CA ;

BRAN, JL ;

MEJIA, CR ;

GARCIA, JF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (01) :128-132

[7] PHARMACOKINETICS OF INTRAVENOUSLY ADMINISTERED CIPROFLOXACIN [J].

WISE, R ;

LOCKLEY, RM ;

WEBBERLY, M ;

DENT, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :208-210

← 1 →